Alignment Healthcare Inc (NASDAQ: ALHC) kicked off on Tuesday, up 0.74% from the previous trading day, before settling in for the closing price of $17.46. Over the past 52 weeks, ALHC has traded in a range of $4.46-$17.76.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 29.34% over the past five years. While this was happening, its average annual earnings per share was recorded 39.95%. With a float of $106.29 million, this company’s outstanding shares have now reached $191.78 million.
Let’s look at the performance matrix of the company that is accounted for 1679 employees. In terms of profitability, gross margin is 10.97%, operating margin of -3.76%, and the pretax margin is -4.74%.
Alignment Healthcare Inc (ALHC) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Healthcare Plans Industry. The insider ownership of Alignment Healthcare Inc is 44.59%, while institutional ownership is 56.44%. The most recent insider transaction that took place on Mar 20 ’25, was worth 460,301. In this transaction Chief Medical Officer of this company sold 26,734 shares at a rate of $17.22, taking the stock ownership to the 509,367 shares. Before that another transaction happened on Mar 20 ’25, when Company’s Officer proposed sale 26,734 for $17.19, making the entire transaction worth $459,557.
Alignment Healthcare Inc (ALHC) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 39.95% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 48.16% during the next five years compared to -22.95% drop over the previous five years of trading.
Alignment Healthcare Inc (NASDAQ: ALHC) Trading Performance Indicators
Take a look at Alignment Healthcare Inc’s (ALHC) current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.67, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.21 in one year’s time.
Technical Analysis of Alignment Healthcare Inc (ALHC)
Alignment Healthcare Inc (NASDAQ: ALHC) saw its 5-day average volume 2.36 million, a positive change from its year-to-date volume of 2.2 million. As of the previous 9 days, the stock’s Stochastic %D was 92.13%. Additionally, its Average True Range was 0.77.
During the past 100 days, Alignment Healthcare Inc’s (ALHC) raw stochastic average was set at 97.31%, which indicates a significant increase from 93.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 32.68% in the past 14 days, which was lower than the 55.13% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.04, while its 200-day Moving Average is $11.51. Nevertheless, the first resistance level for the watch stands at $17.81 in the near term. At $18.03, the stock is likely to face the second major resistance level. The third major resistance level sits at $18.26. If the price goes on to break the first support level at $17.36, it is likely to go to the next support level at $17.12. Assuming the price breaks the second support level, the third support level stands at $16.90.
Alignment Healthcare Inc (NASDAQ: ALHC) Key Stats
The company with the Market Capitalisation of 3.37 billion has total of 191,832K Shares Outstanding. Its annual sales at the moment are 2,704 M in contrast with the sum of -128,040 K annual income. Company’s last quarter sales were recorded 701,240 K and last quarter income was -31,090 K.
